Entera Bio (ENTX) Institutional Ownership $2.10 -0.09 (-4.11%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.10 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Entera Bio (NASDAQ:ENTX)CurrentInstitutional OwnershipPercentage14.11%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$5.14MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$66.36K Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENTX Institutional Buying and Selling by Quarter Entera Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Knoll Capital Management LLC5,881,879$12.47M8.0%+51.5%16.439% 2/14/2025 Schonfeld Strategic Advisors LLC632,311$1.34M0.0%-2.5%1.767% 2/14/2025 Northern Trust Corp212,483$450K0.0%N/A0.594% 1/22/2025 Perigon Wealth Management LLC145,843$325K0.0%N/A0.408% 11/15/2024 Parkman Healthcare Partners LLC411,076$781K0.1%+2.4%1.149% 11/6/2024 Signature Estate & Investment Advisors LLC47,328$90K0.0%N/A0.132% 8/9/2024 Renaissance Technologies LLC57,600$106K0.0%-23.1%0.161% 5/20/2024 Virtu Financial LLC22,040$37K0.0%N/A0.000% 2/14/2023 RA Capital Management L.P.295,966$216K0.0%-85.8%1.028% 11/14/2022 RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229% 1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050% 1/28/2022 ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915% 8/17/2021 Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482% 8/16/2021 RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928% 8/13/2021 Geode Capital Management LLC17,597$105K0.0%N/A0.074% 8/11/2021 Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061% 6/14/2021 Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558% 5/18/2021 Millennium Management LLC38,611$147K0.0%N/A0.163% 5/14/2021 XTX Topco Ltd11,559$44K0.0%N/A0.101% 5/13/2021 Renaissance Technologies LLC120,407$459K0.0%+66.8%1.053% 2/24/2021 Virtu Financial LLC31,314$34K0.0%N/A0.274% 2/10/2021 Renaissance Technologies LLC72,186$78K0.0%N/A0.632% (Data available from 1/1/2016 forward) ENTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Entera Bio shares: Knoll Capital Management LLC ($12.47M), Schonfeld Strategic Advisors LLC ($1.34M), Parkman Healthcare Partners LLC ($781K), Northern Trust Corp ($450K), Perigon Wealth Management LLC ($325K), Renaissance Technologies LLC ($106K), and Signature Estate & Investment Advisors LLC ($90K).Learn more on ENTX's institutional investors. What percentage of Entera Bio stock is owned by institutional investors? 14.11% of Entera Bio stock is owned by institutional investors. Learn more on ENTX's institutional investor holdings. Which institutional investors have been buying Entera Bio stock? The following institutional investors have purchased Entera Bio stock in the last 24 months: Knoll Capital Management LLC ($2M), Northern Trust Corp ($212.48K), Perigon Wealth Management LLC ($145.84K), Signature Estate & Investment Advisors LLC ($47.33K), Virtu Financial LLC ($22.04K), and Parkman Healthcare Partners LLC ($9.56K). How much institutional buying is happening at Entera Bio? Institutional investors have bought a total of 2,437,252 shares in the last 24 months. This purchase volume represents approximately $5.14M in transactions. Which Entera Bio major shareholders have been selling company stock? The following institutional investors have sold Entera Bio stock in the last 24 months: Renaissance Technologies LLC ($17.30K), and Schonfeld Strategic Advisors LLC ($16.29K). How much institutional selling is happening at Entera Bio? Institutional investors have sold a total of 33,589 shares in the last 24 months. This volume of shares sold represents approximately $66.36K in transactions. Related Companies Aurora Cannabis Institutional Ownership Terns Pharmaceuticals Institutional Ownership Foghorn Therapeutics Institutional Ownership Taysha Gene Therapies Institutional Ownership Cryoport Institutional Ownership Annexon Institutional Ownership Corvus Pharmaceuticals Institutional Ownership Trevi Therapeutics Institutional Ownership COMPASS Pathways Institutional Ownership Aquestive Therapeutics Institutional Ownership This page (NASDAQ:ENTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.